Indegene Share Price | On Tuesday, June 3, CNBC-TV18 reported, citing sources that CA Dawn Investments, an affiliate of US-based Carlyle, was likely to sell a 10.2% stake in the healthcare tech firm via block deals valued at approximately ₹1,420 crore.